Dr Kenneth Keeney Renwick, Jr, MD, MPH, FAAFP in Tuolumne, CA - Medicare

Dr Kenneth Keeney Renwick, Jr, MD, MPH, FAAFP is a medicare enrolled "Family Medicine" physician in Tuolumne, California. His current practice location is 18880 Cherry Valley Blvd, Tuolumne, California. You can reach out to his office (for appointments etc.) via phone at (209) 928-5400.

Dr Kenneth Keeney Renwick, Jr is licensed to practice in California (license number G50654) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1659344356.

Contact Information

	Dr Kenneth Keeney Renwick, Jr, MD, MPH, FAAFP
	18880 Cherry Valley Blvd, Tuolumne, CA 95379-9506
	(209) 928-5400
	(209) 928-5412

Physician's Profile

Full Name	Dr Kenneth Keeney Renwick, Jr
Gender	Male
Speciality
Experience	Years
Location	18880 Cherry Valley Blvd, Tuolumne, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Kenneth Keeney Renwick, Jr attended and graduated from in

NPI Data:

NPI Number: 1659344356
Provider Enumeration Date: 02/12/2006
Last Update Date: 03/07/2012

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Kenneth Keeney Renwick, Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659344356	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	G50654 (California)	Secondary
207Q00000X	Family Medicine	G50654 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kenneth Keeney Renwick, Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Kenneth Keeney Renwick, Jr, MD, MPH, FAAFP 18880 Cherry Valley Blvd, Tuolumne, CA 95379-9506 Ph: (209) 928-5400	Dr Kenneth Keeney Renwick, Jr, MD, MPH, FAAFP 18880 Cherry Valley Blvd, Tuolumne, CA 95379-9506 Ph: (209) 928-5400

News Archive

CoreLab Partners releases ImagEngine imaging sciences application

CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine®.

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

The physicians at Orthopaedic & Spine Center have put together an information guide – Surgery Isn't Always the Answer. The resource discusses conservative treatment options for those who suffer from hip, knee, and spine pain. The guide also shares information on the benefits of early diagnosis and minimally-invasive surgical treatments.

George Bush needs more money to cope with bird flu

U.S. President George Bush is about to reveal his plans to fight a flu pandemic and apparently he will ask Congress for funding for a vaccine against bird flu as well as infrastructure to deal with any pandemic.

Inhibition of NLRP3 complex can reduce inflammation in melanoma patients

Cancer doctors may soon have a new tool for treating melanoma and other types of cancer, thanks to work being done by researchers at the University of Colorado Cancer Center.

EPO grants patent for Aeterna Zentaris' perifosine to treat benign, malignant tumours

Aeterna Zentaris Inc. today announced that the European Patent Office has granted a patent for the use of alkyl phosphocholines, more specifically perifosine, in the preparation of a medicament for the treatment of benign and malignant tumours, prior to and/or during the treatment with approved anti-tumour anti-metabolites such as 5FU and capecitabine.

Dr Kenneth Keeney Renwick, Jr, MD, MPH, FAAFP - Medicare in Tuolumne, CA